Literature DB >> 9758130

Delayed-type hypersensitivity to Mycobacterium leprae soluble antigens as a test for infection with the leprosy bacillus.

J A Sterne1, P E Fine, J M Pönnighaus, R J Rees, D Chavula.   

Abstract

BACKGROUND: Mycobacterium leprae (M. leprae) soluble antigen (MLSA) reagents have been developed with the aim of finding a reagent, comparable to tuberculin, which could identify individuals infected with the leprosy bacillus. They have yet to be evaluated fully in human populations.
METHODS: More than 15000 individuals living in a leprosy endemic area of northern Malawi were skin tested with one of five batches of MLSA prepared using two different protocols. The main difference in preparation was the introduction of a high G centrifugation step in the preparation of the last three ('second-generation') batches.
RESULTS: The prevalence of skin-test positivity (delayed-type hypersensitivity (DTH)) and association with the presence of a BCG scar were greater for first (batches A6, A22) than second (batches AB53, CD5, CD19) generation reagents. The association of positivity with M. leprae infection was investigated by comparing results among known (household) contacts of leprosy cases, and among newly diagnosed leprosy patients with those in the general population. While positivity to 'first-generation' antigens appeared to be associated with M. leprae infection, positivity to later antigens was unrelated either to exposure to leprosy cases or presence of leprosy disease. There were geographical differences in the prevalence of DTH to the various batches, probably reflecting exposure to various mycobacteria in the environment.
CONCLUSIONS: Our results suggest that the 'second-generation' batches have lost antigens that can detect M. leprae infections, but that they retain one or more antigens which are shared between M. leprae and environmental mycobacteria. Natural exposure to these both sensitizes individuals and provides natural protection against M. leprae infection or disease. Identification of antigens present in these groups of skin test reagents may assist in production of improved skin test reagents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758130     DOI: 10.1093/ije/27.4.713

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  1 in total

1.  Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.

Authors:  Becky L Rivoire; Nathan A Groathouse; Stephen TerLouw; Kapil Dev Neupane; Chaman Ranjit; Bishwa Raj Sapkota; Saraswoti Khadge; Chhatra B Kunwar; Chatra B Kunwar; Murdo Macdonald; Rachel Hawksworth; Min B Thapa; Deanna A Hagge; Melinda Tibbals; Carol Smith; Tina Dube; Dewei She; Mark Wolff; Eric Zhou; Mamodikoe Makhene; Robin Mason; Christine Sizemore; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.